
SFARI is pleased to announce that it intends to fund 19 grants in response to the Summer 2020 Pilot Award request for applications.
SFARI is pleased to announce that it intends to fund 19 grants in response to the Summer 2020 Pilot Award request for applications.
Phenotypic data from 251,082 participants enrolled in SPARK, including more than 99,000 individuals with ASD, are now available to approved researchers.
New data were recently added to SFARI Gene. This data release included the addition of new genes associated with autism risk, new curated references of copy number variations associated with autism and new mouse models of autism.
SFARI is pleased to announce that Simons Searchlight has launched a research matching program, through which researchers can apply to recruit individuals enrolled in Simons Searchlight into new research studies. Researchers can submit an application via SFARI Base.
A number of presentations will be given by SFARI Investigators at the SfN Global Connectome: A Virtual Event (January 11–13).
New Simons Searchlight data were recently added to SFARI Base. This data release included phenotypic data from individuals with 16p11.2 copy number variants (CNVs), 1q21.1 CNVs, 7q11.23 duplication and variants in 29 single genes associated with autism and related neurodevelopmental conditions.
Autism BrainNet has launched its newly redesigned website. The updated platform has an improved look and feel and new navigation features for a more pleasant, effective and informative user experience.
New data were recently added to SFARI Gene. This data release included the addition of new genes associated with autism risk, new curated references of copy number variations associated with autism and new mouse models of autism.
A number of SFARI Investigators, collaborators and Simons Foundation scientists will present their latest research findings at the American Society of Human Genetics (ASHG) 2020 Virtual Meeting, which will be held October 27–30.
A new collaboration between SFARI and the Nancy Lurie Marks Family Foundation will generate hundreds of induced pluripotent stem cells from individuals with autism and related neurodevelopmental conditions. These cell lines will become available to researchers starting next year.